The published literature has shown a wide range in rates of Achilles tendon pathology, from approximately 6% in the general ...

An Ebola virus outbreak in the Democratic Republic of the Congo and Uganda has surpassed 500 suspected cases, WHO’s top ...

Epioxa, an epithelium-on corneal collagen cross-linking therapy, made a significant and clinically meaningful difference in ...

In response to the Ebola virus outbreak suspected of killing more than 100 people, the CDC has imposed travel restrictions ...

Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1 ...

The anticipated FDA approval of brepocitinib signals an important shift in dermatomyositis management, according to a speaker ...

Guideline-concordant thromboprophylaxis significantly reduces both venous thromboembolism and death in patients at high risk ...

There is a version of this story that ends well.A class of molecules with genuine biological potential, freed from ...

Christopher Lock, MD, spoke with Healio about findings from the Evoke and Evoke+ trials presented at the 2026 American ...

As GLP-1 receptor agonists drive unprecedented weight loss, patients are achieving goal weights but face new aesthetic ...

Obesity is a chronic disease. This statement is clearly at the heart of the answer to this question. When you look at the data in the STEP 1 trial extension, semaglutide (Wegovy, Novo Nordisk) works ...

Lifestyle intervention remains a core component of obesity management, alongside the emergence of more potent pharmacotherapy ...